Paper41233403
Unraveling the structure-activity relationships of organometallic ferrocene-pyrazole and ferrocene-pyrimidine curcumin analogues in amyloid-β aggregation and glioblastoma treatment.
Kovač V and 8 others. Sci Rep, 2025. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Unraveling the structure-activity relationships of organometallic ferrocene-pyrazole and ferrocene-pyrimidine curcumin analogues in amyloid-β aggregation and glioblastoma treatment. Papers, record 41233403. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41233403
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Unraveling the structure-activity relationships of organometallic ferrocene-pyrazole and ferrocene-pyrimidine curcumin analogues in amyloid-β aggregation and glioblastoma treatment.
- PubMed
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Organometallic Compounds | Major topic |
| Curcumin | Major topic |
| Glioblastoma | Major topic |
| Amyloid beta-Peptides | Major topic |
| Protein Aggregation, Pathological | Major topic |
| Brain Neoplasms | Major topic |
| Structure-Activity Relationship | |
| Pyrimidines | |
| Pyrazoles | |
| Ferrous Compounds | |
| Metallocenes | |
| Alzheimer Disease | |
| Apoptosis | |
| Cell Line, Tumor | |
| Cell Survival | |
| Humans | |
| Oxidative Stress | |
| Microscopy, Atomic Force | |
| Mitochondria |
Source PubMed
Grants5
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| HRZZ-IP-2020-02-9162 | Hrvatska Zaklada za Znanost | PubMed | ||
| No. 09-I02-03-V01-00021 | NextGenerationEU | PubMed | ||
| SAS-NSTC-JRP-2024-03_SUPRA-SIGHT | Slovenská Akadémia Vied | PubMed | ||
| 2/0034/22 | Vedecká Grantová Agentúra MŠVVaŠ SR a SAV | PubMed | ||
| No.101007642; PhytoApp | European Union's Horizon 2020 Research and Innovation programme | PubMed |
Source PubMed
References50
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35458736 | Conformational Properties of New Thiosemicarbazone and Thiocarbohydrazone Derivatives and Their Possible Targets. | Molecules | 2022 | https://conductscience.org/library/papers/35458736 | PubMed |
| 2 | 40595248 | Potential role of TNFRSF12A in linking glioblastoma and alzheimer's disease via shared tumour suppressor pathways. | Sci Rep | 2025 | https://conductscience.org/library/papers/40595248 | PubMed |
| 3 | 37631259 | Ferrocene-Based Drugs, Delivery Nanomaterials and Fenton Mechanism: State of the Art, Recent Developments and Prospects. | Pharmaceutics | 2023 | https://conductscience.org/library/papers/37631259 | PubMed |
| 4 | 21696865 | Biological evaluation of twenty-eight ferrocenyl tetrasubstituted olefins: cancer cell growth inhibition, ROS production and hemolytic activity. | Eur J Med Chem | 2011 | https://conductscience.org/library/papers/21696865 | PubMed |
| 5 | 31591298 | Ferrocene-Based Compounds with Antimalaria/Anticancer Activity. | Molecules | 2019 | https://conductscience.org/library/papers/31591298 | PubMed |
| 6 | 31809572 | Interactions between Curcumin Derivatives and Amyloid-β Fibrils: Insights from Molecular Dynamics Simulations. | J Chem Inf Model | 2020 | https://conductscience.org/library/papers/31809572 | PubMed |
| 7 | 28544158 | Molecular and physiological manifestations and measurement of aging in humans. | Aging Cell | 2017 | https://conductscience.org/library/papers/28544158 | PubMed |
| 8 | 19162340 | Tau pathophysiology in neurodegeneration: a tangled issue. | Trends Neurosci | 2009 | https://conductscience.org/library/papers/19162340 | PubMed |
| 9 | 34570963 | Hydroxy-Porphyrin as an Effective, Endogenous Molecular Clamp during Early Stages of Amyloid Fibrillization. | Chem Asian J | 2021 | https://conductscience.org/library/papers/34570963 | PubMed |
| 10 | 19015532 | Molecular structural basis for polymorphism in Alzheimer's beta-amyloid fibrils. | Proc Natl Acad Sci U S A | 2008 | https://conductscience.org/library/papers/19015532 | PubMed |
| 11 | 30316862 | Inhibition of amyloid fibril formation and disassembly of pre-formed fibrils by natural polyphenol rottlerin. | Biochim Biophys Acta Proteins Proteom | 2019 | https://conductscience.org/library/papers/30316862 | PubMed |
| 12 | 34829932 | Autophagy and Apoptosis Induced in U87 MG Glioblastoma Cells by Hypericin-Mediated Photodynamic Therapy Can Be Photobiomodulated with 808 nm Light. | Biomedicines | 2021 | https://conductscience.org/library/papers/34829932 | PubMed |
| 13 | 32008441 | Effect of the fluorescent probes ThT and ANS on the mature amyloid fibrils. | Prion | 2020 | https://conductscience.org/library/papers/32008441 | PubMed |
| 14 | 24842766 | Inhibition of ectopic glioma tumor growth by a potent ferrocenyl drug loaded into stealth lipid nanocapsules. | Nanomedicine | 2014 | https://conductscience.org/library/papers/24842766 | PubMed |
| 15 | 36060240 | The intriguing dose-dependent effect of selected amphiphilic compounds on insulin amyloid aggregation: Focus on a cholesterol-based detergent, Chobimalt. | Front Mol Biosci | 2022 | https://conductscience.org/library/papers/36060240 | PubMed |
| 16 | 33061903 | Mechanisms of Pathogenic Tau and Aβ Protein Spreading in Alzheimer's Disease. | Front Aging Neurosci | 2020 | https://conductscience.org/library/papers/33061903 | PubMed |
| 17 | 28667284 | A molecular hypothesis to explain direct and inverse co-morbidities between Alzheimer's Disease, Glioblastoma and Lung cancer. | Sci Rep | 2017 | https://conductscience.org/library/papers/28667284 | PubMed |
| 18 | 34638742 | Heterogeneity of Response to Iron-Based Metallodrugs in Glioblastoma Is Associated with Differences in Chemical Structures and Driven by FAS Expression Dynamics and Transcriptomic Subtypes. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34638742 | PubMed |
| 19 | 32202581 | Ferrocene-modified peptides as inhibitors against insulin amyloid aggregation based on molecular simulation. | J Mater Chem B | 2020 | https://conductscience.org/library/papers/32202581 | PubMed |
| 20 | 35964143 | Perspectives and challenges in patient stratification in Alzheimer's disease. | Alzheimers Res Ther | 2022 | https://conductscience.org/library/papers/35964143 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| APP | 351 | PubTator's text mining | https://conductscience.org/library/genes/351 | NCBI Gene |
| TUBA1B | 10376 | PubTator's text mining | https://conductscience.org/library/genes/10376 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41233403
GET https://conductscience.org/api/papers/v1/41233403/references?page=2